Reducing Cardiovascular Morbidity and Mortality With the Statins
نویسندگان
چکیده
منابع مشابه
Reducing morbidity and mortality in high risk patients with statins
Residual coronary heart disease remains a significant problem even after adequate statin therapy for cardiovascular risk reduction as currently recommended by the Adult Treatment Panel III (ATP-III) of the National Cholesterol Education Program (NCEP). This is particularly true for the high risk patients as defined by ATP-III that includes those patients who have a greater than 20% 10-year risk...
متن کاملTargeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality
1 DiNicolantonio JJ, et al. Open Heart 2017;4:e000642. doi:10.1136/openhrt-2017-000642 CliniCal impaCt of aspirin resistanCe The failure of daily aspirin therapy to achieve an adequate or ‘normal’ suppression of platelet aggregation, as assessed ex vivo, is known as ‘aspirin resistance’. 2 A substantial fraction of patients classified as aspirin-resistant are in fact poorly compliant. In other ...
متن کاملVHRM-3389-reducing morbidity and mortality
Correspondence: Prakash Deedwania Chief, Cardiology Division, VACCHCS/ UCSF, 2615 e. Clinton Avenue, Fresno, CA 93703, USA email [email protected] Vibhuti Singh Clinical Assistant Professor of Medicine, Suncoast Cardiovascular Center, 601 7th Street South, St. Petersburg, FL 33701, USA [email protected] or [email protected] Abstract: Residual coronary heart disease remains a signi...
متن کاملCardiovascular morbidity and mortality associated with the metabolic syndrome.
OBJECTIVE To estimate the prevalence of and the cardiovascular risk associated with the metabolic syndrome using the new definition proposed by the World Health Organization RESEARCH DESIGN AND METHODS A total of 4,483 subjects aged 35-70 years participating in a large family study of type 2 diabetes in Finland and Sweden (the Botnia study) were included in the analysis of cardiovascular risk...
متن کاملCardiovascular morbidity and mortality after kidney transplantation.
Kidney transplantation is the optimal treatment for patients with end stage renal disease (ESRD) who would otherwise require dialysis. Patients with ESRD are at dramatically increased cardiovascular (CV) risk compared with the general population. As well as improving quality of life, successful transplantation accords major benefits by reducing CV risk in these patients. Worldwide, cardiovascul...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of the American Board of Family Medicine
سال: 1998
ISSN: 1557-2625,1558-7118
DOI: 10.3122/15572625-11-1-57